Hypofibrinogenemia
9
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
56%
5 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding
Comparative Effectiveness of INTERCEPT Fibrinogen Complex (IFC) and Cryoprecipitate-AHF (Cryo-AHF) for Treatment of Trauma Associated Hemorrhage
A Point-of-care Electrochemical-based Device for Rapid Detection of Fibrinogen on Type A Aortic Dissection Surgery
Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence
Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness
FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis
Fibrinogen Concentrate (Human) - Efficacy and Safety Study
Human Fibrinogen Concentrate in Pediatric Cardiac Surgery
Fibrinogen Concentrate In Children Cardiac Surgery 2